载脂蛋白CIII在非酒精性脂肪性肝病中的作用研究进展
被引量:1
摘要
非酒精性脂肪性肝病(NAFLD)在发达国家和我国富裕地区已经超过病毒性肝炎成为慢性肝病的首要病因,严重影响人们的健康及生活。NAFLD由环境因素和遗传因素共同决定,其发生发展常伴随高甘油三脂血症(HTG)。载脂蛋白CIII(ApoCIII)在脂质代谢中起重要作用,它可通过多种途径增加血浆甘油三酯(TG)水平,引起HTG。
出处
《肝脏》
2017年第2期162-164,共3页
Chinese Hepatology
基金
青年科学基金项目(81500456)
二级参考文献11
-
1K. G. M. M.Alberti,P.Zimmet,J.Shaw.Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes Federation[J]. Diabetic Medicine . 2006 (5)
-
2Curtis K. Argo,Stephen H. Caldwell.Epidemiology and Natural History of Non-Alcoholic Steatohepatitis[J].Clinics in Liver Disease.2009(4)
-
3S. Lallukka,K. Sevastianova,J. Perttil?,A. Hakkarainen,M. Orho-Melander,N. Lundbom,V. M. Olkkonen,H. Yki-J?rvinen.Adipose tissue is inflamed in NAFLD due to obesity but not in NAFLD due to genetic variation in PNPLA3[J].Diabetologia.2013(4)
-
4Dinesh Khanna,John D. Fitzgerald,Puja P. Khanna,Sangmee Bae,Manjit K. Singh,Tuhina Neogi,Michael H. Pillinger,Joan Merill,Susan Lee,Shraddha Prakash,Marian Kaldas,Maneesh Gogia,Fernando Perez‐Ruiz,Will Taylor,Frédéric Lioté,Hyon Choi,Jasvinder A. Singh,Nicola Dalbeth,Sanford Kaplan,Vandana Niyyar,Danielle Jones,Steven A. Yarows,Blake Roessler,Gail Kerr,Charles King,Gerald Levy,Daniel E. Furst,N. Lawrence Edwards,Brian Mandell,H. Ralph Schumacher,Mark Robbins,Neil Wenger,Rober.2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia[J].Arthritis Care Res.2012(10)
-
5K. Gariani,J. Philippe,F.R. Jornayvaz.Non-alcoholic fatty liver disease and insulin resistance: From bench to bedside[J].Diabetes and Metabolism.2012
-
6Yan Ding,Ming An Zhu,Zhi Xiao Wang,Jing Zhu,Jing Bo Feng,Dong Sheng Li,Momiao Xiong.Associations of Polymorphisms in the Apolipoprotein APOA1-C3-A5 Gene Cluster with Acute Coronary Syndrome[J].Journal of Biomedicine and Biotechnology.2012
-
7Philip Greenland,Joseph S. Alpert,George A. Beller,Emelia J. Benjamin,Matthew J. Budoff,Zahi A. Fayad,Elyse Foster,Mark A. Hlatky,John McB. Hodgson,Frederick G. Kushner,Michael S. Lauer,Leslee J. Shaw,Sidney C. Smith,Allen J. Taylor,William S. Weintraub,Nanette K. Wenger.2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults[J].Journal of the American College of Cardiology.2010(25)
-
8Jian-Gao Fan,Geoffrey C. Farrell.Epidemiology of non-alcoholic fatty liver disease in China[J].Journal of Hepatology.2008(1)
-
9Michael Miller,Jeffrey Rhyne,Hegang Chen,Valerie Beach,Richard Ericson,Kalpana Luthra,Manjari Dwivedi,Anoop Misra.APOC3 Promoter Polymorphisms C-482T and T-455C Are Associated with the Metabolic Syndrome 1[J].Archives of Medical Research.2007(4)
-
10Brent A. Neuschwander-Tetri,Stephen H. Caldwell.Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference[J].Hepatology.2003(5)
共引文献6
-
1高先春,杨玲.非肥胖人群非酒精性脂肪性肝病流行现状及相关危险因素[J].临床内科杂志,2015,32(5):297-299. 被引量:6
-
2薛现然,田执梁.儿童非酒精性脂肪性肝病相关基因研究进展[J].国际遗传学杂志,2018,41(3):212-218.
-
3徐聪,蔺志杰,龚卫娟,贾筱琴,李国利.载脂蛋白C3转基因小鼠脾脏免疫细胞表型及其活性分析[J].癌变.畸变.突变,2019,31(3):208-215.
-
4邴浩,李异玲.非酒精性脂肪性肝病的相关基因学概述[J].胃肠病学和肝病学杂志,2019,28(7):835-838. 被引量:1
-
5李彤,王鸣璐,李莹,肇丽梅.脂类代谢相关基因多态性在非酒精性脂肪肝病中的研究进展[J].中国药学杂志,2022,57(3):170-175. 被引量:2
-
6Kanuengnit Choochuay,Punna Kunhapan,Apichaya Puangpetch,Sissades Tongsima,Pornpen Srisawasdi,Abhasnee Sobhonslidsuk,Somnuek Sungkanuparph,Mohitosh Biswas,Chonlaphat Sukasem.Associations of PNPLA3 and LEP genetic polymorphisms with metabolic-associated fatty liver disease in Thai people living with human immunodeficiency virus[J].World Journal of Hepatology,2024,16(3):366-378.
同被引文献22
-
1管红雨,蔡晓波,陆伦根.缺氧对非酒精性脂肪性肝病发病的影响[J].实用肝脏病杂志,2016,19(2):237-240. 被引量:5
-
2宣世英,袁晨,芦琳琳,辛永宁.非酒精性脂肪性肝病相关易感基因及其在发病机制中的作用[J].临床肝胆病杂志,2016,32(3):446-452. 被引量:9
-
3隋云鹏,朱莉莉,隋峰.神经再生抑制分子Nogo-A的病生理机制研究进展[J].医学分子生物学杂志,2016,13(2):115-119. 被引量:12
-
4侯艺鑫,王宪波,杨玉英,江宇泳.中医药防治非酒精性脂肪性肝病的作用机制[J].临床肝胆病杂志,2016,32(4):785-789. 被引量:23
-
5刘昱含,谢青.多重“打击”在非酒精性脂肪性肝病发病过程中的作用[J].肝脏,2016,21(3):219-221. 被引量:13
-
6吴黎艳,陆增生,陈芝芸.自噬在非酒精性脂肪性肝病中的研究进展[J].中西医结合肝病杂志,2016,26(3):191-192. 被引量:4
-
7张涵,陈宏,陈容平,易敏.非酒精性脂肪肝病患者血清betatrophin浓度及其与代谢参数的相关性[J].实用医学杂志,2016,32(16):2689-2692. 被引量:4
-
8刘志成,苑荣亮,张成,汪玉婷,黄芬,井申荣.人星状病毒非结构蛋白nsP1 a/1相互作用的宿主细胞靶蛋白筛选[J].医学分子生物学杂志,2016,13(5):281-285. 被引量:7
-
9张艳,杨波,包明威,张炳山,武欣迎,王澈,李海涛,梁锦军.Nek6在心力衰竭家兔心脏中的表达增加[J].医学分子生物学杂志,2016,13(6):317-321. 被引量:6
-
10王倩,吴鹏波,柳健,谭诗云.二甲双胍在非酒精性脂肪性肝病治疗作用中的研究进展[J].胃肠病学和肝病学杂志,2017,26(3):348-351. 被引量:6
-
1章卫东,宣英琴,李湘生,周义红.富裕地区农村人群肥胖的现况调查[J].江苏预防医学,2000,11(2):13-14.
-
2范建高.提高对非酒精性脂肪性肝病危害的认识[J].国外医学(消化系疾病分册),2005,25(5):323-324. 被引量:8
-
3展玉涛.非酒精性脂肪性肝病与心血管疾病[J].中华内科杂志,2007,46(10):868-869. 被引量:4
-
4樊宁,王劲,李丽华.非酒精性脂肪肝及其合并代谢综合征患者血清载脂蛋白CⅢ水平的分析[J].国际检验医学杂志,2011,32(10):1130-1131. 被引量:1
-
5黄洁蓉,陈韶华,虞朝辉,厉有名.载脂蛋白CⅢ基因多态性与非酒精性脂肪性肝病的相关性[J].中华内科杂志,2010,49(5):434-435. 被引量:1
-
6研究找到延缓1型糖尿病的方法[J].糖尿病天地(文摘刊),2011(7):47-47.
-
7徐有青.小心悄悄来袭的脂肪肝[J].糖尿病天地,2008(5):29-29.
-
8范建高.正确认识脂肪肝的危害[J].中华全科医师杂志,2007,6(4):199-200. 被引量:25
-
9范建高,徐正婕.重视非酒精性脂肪性肝病的规范化诊断与治疗[J].临床消化病杂志,2007,19(4):201-201. 被引量:1
-
10穆鑫,周旭晨,刘少奎,张志超.原发性高血压与载脂蛋白CⅢ-455C基因量的关系[J].中国综合临床,2009,25(11):1154-1156.